BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8723288)

  • 1. Intensified VICE regimen may improve SCLC survival.
    Oncology (Williston Park); 1996 Apr; 10(4):554. PubMed ID: 8723288
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
    Lorigan P; Lee SM; Betticher D; Woodhead M; Weir D; Hanley S; Hardy C; Thatcher N
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):32-41. PubMed ID: 7610397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Ettinger DS
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive combined-modality therapy in small cell lung cancer.
    Thatcher N; Lorrigan P; Burt P; Stout R
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):9-22. PubMed ID: 8052879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ifosfamide in small cell lung cancer.
    Loehrer PJ
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diseases desperate grown.
    Bunn PA
    J Natl Cancer Inst; 2008 Apr; 100(8):520-1. PubMed ID: 18398099
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
    Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide in the treatment of small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):2-6. PubMed ID: 8677443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
    Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
    Postmus PE; Smit EF; Berendsen HH; Haaxma-Reiche H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):17-23. PubMed ID: 1329219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of small cell lung cancer in elderly.
    Satoh H; Ishikawa H; Funayama Y; Yamashita YT; Kamma H; Ohtsuka M; Sekizawa K
    Anticancer Res; 1999; 19(5C):4507-10. PubMed ID: 10650801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide in small cell lung cancer.
    Einhorn LH
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
    Sandler AB
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.